← Leaderboards
Thomas M Wisniewski
Nathan S. Kline Institute For Psych Res
$40,874,523
Attributed
$62,392,270
Total exposure
29
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.2M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$100,501,570 · 31
CDC$2,399,803 · 1
By mechanism
P30$38,041,380 · 12
R01$23,151,675 · 6
P01$17,013,160 · 5
RF1$11,358,705 · 3
U24$8,275,432 · 2
U01$2,399,803 · 1
Top collaborators
- Yulin Ge9 shared
- Helen E Scharfman9 shared
- Jorge A Busciglio5 shared
- A Claudio Cuello5 shared
- Juan Fortea5 shared
- Jennifer Ann Frontera4 shared
- Joan Reibman4 shared
- Yongzhao Shao4 shared
Most similar at Nathan S. Kline Institute For Psych Res
Same institution · by research overlap
- Jorge A Ghiso$12,759,277
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseasePathologyNeuropathologyAmyloidProteomicsDementiaBiological MarkersNeuroimagingCognitiveMagnetic Resonance ImagingProgramsIn VivoCollaborationsTau ProteinsResearch PersonnelCommunitiesImpaired CognitionBrainPreventFundingAutopsyData ManagementDiagnosis
Grant awards (158)
ARIA Pathophysiology Characterized by in vivo Neuroimaging, Plasma Biomarkers and Post-Mortem Proteomics$3,310,951
U24 · FY2025 · NS · contact PI
Multi-scale and multi-modality imaging of neuropathology in VCID$1,642,682
U24 · FY2025 · NS
Alzheimerâs Disease Related Biomarkers following SARS-CoV-2 Infection$1,361,420
R01 · FY2025 · AG · contact PI
Alzheimer's Disease Research Center - Administrative Supplement 2025$1,271,250
P30 · FY2025 · AG · contact PI
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$802,150
R01 · FY2025 · AG
Cognitive decline among WTC survivors with chronic mental and physical disorders$599,959
U01 · FY2025 · OH
Postdoctoral Research Training in Alzheimer's Disease and Related Neurodegenerative Disorders$356,462
T32 · FY2025 · AG · contact PI
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$259,200
R01 · FY2025 · AG
Administrative Core$158,907
P30 · FY2025 · AG · contact PI
Neuropathology Core$158,906
P30 · FY2025 · AG · contact PI
Biomarker Core$158,906
P30 · FY2025 · AG · contact PI
Alzheimer's Disease Research Center$3,125,391
P30 · FY2024 · AG · contact PI
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease$2,314,645
P01 · FY2024 · AG · contact PI
Multi-scale and multi-modality imaging of neuropathology in VCID$1,633,010
U24 · FY2024 · NS
Alzheimerâs Disease Related Biomarkers following SARS-CoV-2 Infection$1,389,203
R01 · FY2024 · AG · contact PI
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$1,105,775
R01 · FY2024 · AG
Cognitive decline among WTC survivors with chronic mental and physical disorders$599,945
U01 · FY2024 · OH
Administrative Core$539,760
P30 · FY2024 · AG · contact PI
Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD$514,446
P01 · FY2024 · AG · contact PI
Postdoctoral Research Training in Alzheimer's Disease and Related Neurodegenerative Disorders$352,075
T32 · FY2024 · AG · contact PI
Neuropathology Core$228,685
P30 · FY2024 · AG · contact PI
Biomarker Core$225,953
P30 · FY2024 · AG · contact PI
Administrative Core$132,965
P01 · FY2024 · AG · contact PI
Alzheimer's Disease Research Center$39,934
P30 · FY2024 · AG · contact PI
Alzheimer's Disease Research Center$26,623
P30 · FY2024 · AG · contact PI
Alzheimer's Disease Research Center$3,171,322
P30 · FY2023 · AG · contact PI
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease$2,358,523
P01 · FY2023 · AG · contact PI
Multi-scale and multi-modality imaging of neuropathology in VCID$1,688,789
U24 · FY2023 · NS
Alzheimerâs Disease Related Biomarkers following SARS-CoV-2 Infection$1,389,203
R01 · FY2023 · AG · contact PI
Cognitive decline among WTC survivors with chronic mental and physical disorders$599,950
U01 · FY2023 · OH
Administrative Core$574,717
P30 · FY2023 · AG · contact PI
Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD$514,519
P01 · FY2023 · AG · contact PI
Postdoctoral Research Training in Alzheimer's Disease and Related Neurodegenerative Disorders$330,950
T32 · FY2023 · AG · contact PI
Biomarker Core$242,487
P30 · FY2023 · AG · contact PI
Neuropathology Core$231,669
P30 · FY2023 · AG · contact PI
Alzheimer's Disease Research Center$159,740
P30 · FY2023 · AG · contact PI
Alzheimer's Disease Research Center$159,740
P30 · FY2023 · AG · contact PI
Administrative Core$129,574
P01 · FY2023 · AG · contact PI
Alzheimer's Disease Research Center$3,214,632
P30 · FY2022 · AG · contact PI
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease$2,398,861
P01 · FY2022 · AG · contact PI
Alzheimerâs Disease Related Biomarkers following SARS-CoV-2 Infection$1,378,414
R01 · FY2022 · AG · contact PI
Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD$620,426
P01 · FY2022 · AG · contact PI
Cognitive decline among WTC survivors with chronic mental and physical disorders$599,949
U01 · FY2022 · OH
Administrative Core$524,924
P30 · FY2022 · AG · contact PI
Biomarker Core$320,372
P30 · FY2022 · AG · contact PI
Neuropathology Core$272,426
P30 · FY2022 · AG · contact PI
Postdoctoral Research Training in Alzheimer's Disease and Related Neurodegenerative Disorders$229,174
T32 · FY2022 · AG · contact PI
Alzheimer's Disease Research Center- Supplement 3.2- Mark Bernard 2022$133,117
P30 · FY2022 · AG · contact PI
Administrative Core$126,184
P01 · FY2022 · AG · contact PI
Alzheimer's Disease Research Center- Supplement 3.1- Anthony Briggs 2022$119,804
P30 · FY2022 · AG · contact PI
Alzheimer's Disease Research Center$3,249,827
P30 · FY2021 · AG · contact PI
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease$2,447,228
P01 · FY2021 · AG · contact PI
Administrative Core$811,000
P30 · FY2021 · AG · contact PI
Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD$634,903
P01 · FY2021 · AG · contact PI
Biomarker Core$304,582
P30 · FY2021 · AG · contact PI
Neuropathology Core$287,987
P30 · FY2021 · AG · contact PI
Postdoctoral Research Training in Neurodegenerative Disorders and the Aging Brain$228,712
T32 · FY2021 · AG · contact PI
Administrative Core$126,184
P01 · FY2021 · AG · contact PI
Alzheimer's Disease Research Center$3,318,934
P30 · FY2020 · AG · contact PI
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease$2,484,793
P01 · FY2020 · AG · contact PI
Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD$634,976
P01 · FY2020 · AG · contact PI
Administrative Core$603,347
P30 · FY2020 · AG · contact PI
The Role of Inflammation and NGF Dysfunction in the Evolution of AlzheimerDisease Pathology in Down syndrome$563,692
RF1 · FY2020 · AG
Alzheimer's Disease Research Center$421,038
P30 · FY2020 · AG · contact PI
Biomarker Core$359,030
P30 · FY2020 · AG · contact PI
Alzheimer's Disease Research Center$348,851
P30 · FY2020 · AG · contact PI
Neuropathology Core$325,447
P30 · FY2020 · AG · contact PI
Postdoctoral Research Training in Neurodegenerative Disorders and the Aging Brain$224,642
T32 · FY2020 · AG · contact PI
Administrative Core$124,489
P01 · FY2020 · AG · contact PI
Alzheimer's Disease Core Center$1,881,451
P30 · FY2019 · AG · contact PI
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease$370,781
R01 · FY2019 · NS · contact PI
Core A. Administrative Core$313,573
P30 · FY2019 · AG · contact PI
Postdoctoral Research Training in Neurodegenerative Disorders and the Aging Brain$216,607
T32 · FY2019 · AG · contact PI
Core D. Neuropathology Core (with IBR Subcontract)$192,336
P30 · FY2019 · AG · contact PI
Mechanisms of age-related white matter hyperintensities: insights from advanced MRI$3,580,140
RF1 · FY2018 · NS
The Role of Inflammation and NGF Dysfunction in the Evolution of AlzheimerDisease Pathology in Down syndrome$3,260,720
RF1 · FY2018 · AG
Alzheimer's Disease Core Center$1,874,582
P30 · FY2018 · AG · contact PI
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease$370,781
R01 · FY2018 · NS · contact PI
Postdoctoral Research Training in Neurodegenerative Disorders and the Aging Brain$207,120
T32 · FY2018 · AG · contact PI
Core D. Neuropathology Core (with IBR Subcontract)$192,336
P30 · FY2018 · AG · contact PI
Alzheimer's Disease Core Center$169,500
P30 · FY2018 · AG · contact PI
Characterization of Rapidly Progressive Alzheimer's Disease$3,954,153
RF1 · FY2017 · AG · contact PI
Alzheimer's Disease Core Center$1,871,900
P30 · FY2017 · AG · contact PI
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease$370,781
R01 · FY2017 · NS · contact PI
Core D. Neuropathology Core (with IBR Subcontract)$192,336
P30 · FY2017 · AG · contact PI
Postdoctoral Research Training in Neurodegenerative Disorders and the Aging Brain$134,940
T32 · FY2017 · AG · contact PI
Alzheimer's Disease Core Center$1,863,909
P30 · FY2016 · AG · contact PI
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease$370,781
R01 · FY2016 · NS · contact PI
Core A. Administrative Core$314,015
P30 · FY2016 · AG · contact PI
Detection and Clearance of AD Lesions$277,160
R01 · FY2016 · AG · contact PI
Core D. Neuropathology Core (with IBR Subcontract)$191,632
P30 · FY2016 · AG · contact PI
Alzheimer's Disease Core Center$1,883,508
P30 · FY2015 · AG · contact PI
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease$370,781
R01 · FY2015 · NS · contact PI
Detection and Clearance of AD Lesions$268,845
R01 · FY2015 · AG · contact PI
Core D. Neuropathology Core (with IBR Subcontract)$209,711
P30 · FY2015 · AG · contact PI
Alzheimer's Disease Core Center$200,000
P30 · FY2015 · AG · contact PI
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease$358,670
R01 · FY2014 · NS · contact PI
Detection and Clearance of AD Lesions$277,160
R01 · FY2014 · AG · contact PI
Therapeutic Approaches for Prion Disease$349,614
R01 · FY2013 · NS · contact PI
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease$349,614
R01 · FY2013 · NS · contact PI
Detection and Clearance of AD Lesions$261,916
R01 · FY2013 · AG · contact PI
NEUROPATHOLOGY CORE$77,123
P30 · FY2013 · AG · contact PI
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease$362,294
R01 · FY2012 · NS · contact PI
Therapeutic Approaches for Prion Disease$362,294
R01 · FY2012 · NS · contact PI
Detection and Clearance of AD Lesions$277,160
R01 · FY2012 · AG · contact PI
NEUROPATHOLOGY CORE$86,097
P30 · FY2012 · AG · contact PI
Therapeutic Approaches for Prion Disease$362,294
R01 · FY2011 · NS · contact PI
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease$362,294
R01 · FY2011 · NS · contact PI
Detection and Clearance of AD Amyloid Lesions$291,637
R01 · FY2011 · AG · contact PI
NEUROPATHOLOGY CORE$82,363
P30 · FY2011 · AG · contact PI
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease$369,688
R01 · FY2010 · NS · contact PI
Therapeutic Approaches for Prion Disease$365,991
R01 · FY2010 · NS · contact PI
Detection and Clearance of AD Amyloid Lesions$303,408
R01 · FY2010 · AG · contact PI
NEUROPATHOLOGY CORE$82,972
P30 · FY2010 · AG · contact PI
Therapeutic Approaches for Prion Disease$1,242,287
R01 · FY2009 · NS · contact PI
Therapeutic Approaches for Prion Disease$370,052
R01 · FY2009 · NS · contact PI
Detection and Clearance of AD Amyloid Lesions$306,473
R01 · FY2009 · AG · contact PI
Amyloid beta Peptide and Apolipoprotein E$289,734
R01 · FY2009 · AG · contact PI
NEUROPATHOLOGY CORE$257,498
P30 · FY2009 · AG · contact PI
Therapeutic Approaches for Prion Disease$370,561
R01 · FY2008 · NS · contact PI
Detection and Clearance of AD Amyloid Lesions$306,322
R01 · FY2008 · AG · contact PI
Amyloid beta Peptide and Apolipoprotein E$289,734
R01 · FY2008 · AG · contact PI
NEUROPATHOLOGY CORE$276,314
P30 · FY2008 · AG · contact PI
Immunization Approaches for Alzheimer's Disease$116,885
R21 · FY2008 · AG · contact PI
Therapeutic Approaches for Prion Disease$370,561
R01 · FY2007 · NS · contact PI
Detection and Clearance of AD Amyloid Lesions$311,805
R01 · FY2007 · AG · contact PI
Amyloid beta Peptide and Apolipoprotein E$295,647
R01 · FY2007 · AG · contact PI
NEUROPATHOLOGY CORE$250,567
P30 · FY2007 · AG · contact PI
Immunization Approaches for Alzheimer's Disease$133,561
R21 · FY2007 · AG · contact PI
Mucosal Vaccination for Prion Disease$42,175
R03 · FY2007 · TW · contact PI
Therapeutic Approaches for Prion Disease$381,629
R01 · FY2006 · NS · contact PI
Detection and Clearance of AD Amyloid Lesions$352,749
R01 · FY2006 · AG · contact PI
Amyloid beta Peptide and Apolipoprotein E$304,477
R01 · FY2006 · AG · contact PI
NEUROPATHOLOGY CORE$117,852
P30 · FY2006 · AG · contact PI
Mucosal Vaccination for Prion Disease$43,435
R03 · FY2006 · TW · contact PI
Therapeutic Approaches for Prion Disease$390,813
R01 · FY2005 · NS
Detection and Clearance of AD Amyloid Lesions$361,238
R01 · FY2005 · AG
Amyloid beta Peptide and Apolipoprotein E$311,805
R01 · FY2005 · AG
NEUROPATHOLOGY CORE$111,992
P30 · FY2005 · AG
Mucosal Vaccination for Prion Disease$44,480
R03 · FY2005 · TW
Therapeutic Approaches for Prion Disease$390,813
R01 · FY2004 · NS
Detection and Clearance of AD Amyloid Lesions$361,238
R01 · FY2004 · AG
Detection and Clearance of AD Amyloid Lesions$360,614
R01 · FY2003 · AG
Detection and Clearance of AD Amyloid Lesions$359,545
R01 · FY2002 · AG
Ischemic and Vascular Pathology in Alzheimer's Disease$268,419
P01 · FY2002 · AG
Core--Neuropathology$268,419
P01 · FY2002 · AG
AMYLOID BETA PEPTIDE AND THEIR BINDING PROTEINS$234,858
R01 · FY2002 · AG
Core--Neuropathology$228,402
P01 · FY2001 · AG
Ischemic and Vascular Pathology in Alzheimer's Disease$228,401
P01 · FY2001 · AG
AMYLOID BETA PEPTIDE AND THEIR BINDING PROTEINS$228,027
R01 · FY2001 · AG
Core--Neuropathology$0
P01 · FY2001 · AG
Core--Neuropathology$0
P01 · FY2001 · AG
Ischemic and Vascular Pathology in Alzheimer's Disease$0
P01 · FY2001 · AG
Ischemic and Vascular Pathology in Alzheimer's Disease$0
P01 · FY2001 · AG
CORE--NEUROPATHOLOGY$258,505
P30 · FY2000 · AG
Core--Neuropathology$228,402
P01 · FY2000 · AG
Ischemic and Vascular Pathology in Alzheimer's Disease$228,401
P01 · FY2000 · AG
AMYLOID BETA PEPTIDE AND THEIR BINDING PROTEINS$221,384
R01 · FY2000 · AG